Engsit

ENGSIT

Ondansetron

ENGLISH PHARMACEUTICALS INDUSTRIES

Drug Identity

Active Ingredient
Ondansetron
Drug Class
Antiemetics & Antinauseants
ATC Code
A04AA01
Status
Essential Medicine

How It Works

IM: Should be given undiluted. IV: Give first dose 30 min prior to beginning chemotherapy; the IV preparation has been successful when administered orally. IVPB: Infuse over 15-30 min; 24-hour continuous infusions have been reported, but are rarely used. RECONSTITUTION: Prior to IV infusion, dilute in 50-100 ml D5W or NS.

How to Take It

Dosage information not available for this product.

Important Warnings

Hepatic impairment, adenotonsillar surgery, sub acute intestinal obstruction, susceptibility to QT-interval prolongation(including electrolyte disturbances)

Side Effects

Constipationheadacheflushingarrhythmiasbradycardiachest painhiccupshypotensionmovement disordersseizuretransient rise in liver enzymesST segment depressionextra-pyramidal reactionsvisual disturbance.

Drug Interactions

Tramadol
Phenytoin
rifampicin
carbamazepine

Pregnancy & Lactation

Pregnancy
Caution advised
Lactation
Caution advised

Price Intelligence

Rs 2,885.81
DRAP approved maximum price · 5's x2ml · approved 27 Jul, 2026
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
DRAP5's x2mlRs 2,885.81

Should you consider an alternative?

Other options containing Ondansetron, and what they are not.

Same active ingredient, a different dose. Never switch strength without your doctor or pharmacist.

Ordered by lowest price per unit where a pack size is known, then by price. Order is never affected by sponsorship. Not medical advice — confirm any change with your pharmacist or doctor.

For pharma professionalsCompany, market and opportunity intelligence

Company

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.